BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Treatment
533 results:

  • 1. Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction.
    Bostel T; Nikolaidou E; Wollschläger D; Mayer A; Kaufmann J; Hopprich A; Rühle A; Grosu AL; Debus J; Fottner C; Moehler M; Grimminger P; Schmidberger H; Nicolay NH
    Radiat Oncol; 2024 Mar; 19(1):28. PubMed ID: 38433231
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers.
    Ma T; Song Q; Cheng B; Guo E; Wang X; Li M; Dai M; Li S; Feng S; Yu B
    Bioorg Chem; 2024 Mar; 144():107142. PubMed ID: 38280358
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A case report of cardia carcinoma: Underwent Heller myotomy for Achalasia.
    Wen LQ; Wei DW
    Medicine (Baltimore); 2024 Jan; 103(4):e36924. PubMed ID: 38277562
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Survival Outcomes and Patterns of Care for Stage II or III Resected gastric cancer by Race and Ethnicity.
    Wu SP; Keshavjee SH; Yoon SS; Kwon S
    JAMA Netw Open; 2023 Dec; 6(12):e2349026. PubMed ID: 38127346
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathologic features and prognosis of 71 patients with gastric cancer and disseminated intravascular coagulation.
    Chen L; Lin J; Chen Y; Yu J; Wang X
    PeerJ; 2023; 11():e16527. PubMed ID: 38034872
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer.
    Janczewski LM; Logan CD; Vitello DJ; Buchheit JT; Abad JD; Bentrem DJ; Chawla A
    J Surg Oncol; 2024 Mar; 129(3):481-488. PubMed ID: 37986548
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identifying the optimal treatment strategy in patients with resectable non-cardia gastric cancer.
    Ajay PS; Rajamanickam RK; Rhee K; NeMoyer R; Goyal S; Switchenko JM; Lin Y; Jabbour SK; Carpizo DR; Kennedy TJ; Shah MM
    Surg Endosc; 2024 Jan; 38(1):136-147. PubMed ID: 37935921
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in gastric cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.
    Rau B; Lang H; Koenigsrainer A; Gockel I; Rau HG; Seeliger H; Lerchenmueller C; Reim D; Wahba R; Angele M; Heeg S; Keck T; Weimann A; Topp S; Piso P; Brandl A; Schuele S; Jo P; Pratschke J; Wegel S; Rehders A; Moosmann N; Gaedcke J; Heinemann V; Trips E; Loeffler M; Schlag PM; Thuss-Patience P
    J Clin Oncol; 2024 Jan; 42(2):146-156. PubMed ID: 37906724
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Splenic hilar lymph node dissection enhances survival in Bormann type 4 gastric cancer.
    Jeong O; Lee HH; Hur H; Kim HI
    Sci Rep; 2023 Sep; 13(1):15390. PubMed ID: 37717100
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus.
    Åkerström JH; Santoni G; von Euler Chelpin M; Ness-Jensen E; Kauppila JH; Holmberg D; Lagergren J
    Gastroenterology; 2024 Jan; 166(1):132-138.e3. PubMed ID: 37690771
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A preoperative predictive tool to assess the need for staging laparoscopy in oesophagogastric cancer patients.
    Halle-Smith JM; Bage T; Kamarajah SK; Siddaiah-Subramanya M; Pande R; Whiting JL; Griffiths EA
    Ann R Coll Surg Engl; 2024 Apr; 106(4):369-376. PubMed ID: 37642164
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Skip metastasis at the esophageal resection margin in radical gastrectomy: clinical characteristics of 30 cases].
    Liu S; Xia QY; Fu Y; Lu XF; Wang M; Guan WX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):675-679. PubMed ID: 37583025
    [No Abstract]    [Full Text] [Related]  

  • 13. Decision to perform additional surgery after non-curative endoscopic submucosal dissection for gastric cancer based on the risk of lymph node metastasis: a long-term follow-up study.
    Lee S; Kim SG; Cho SJ
    Surg Endosc; 2023 Oct; 37(10):7738-7748. PubMed ID: 37567980
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. gastric cancer Surgery in the US: a Contemporary Trend Analysis of Lymphadenectomy and the Impact of Minimally Invasive Approaches.
    Maegawa FB; Patel AD; Serrot FJ; Patel SG; Stetler JL; Patel DC; Ghaderi I; Hsu CH; Ashouri Y; Sarmiento JM; Konstantinidis IT; Lin E
    J Gastrointest Surg; 2023 Sep; 27(9):1825-1836. PubMed ID: 37340110
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population-based registry data.
    Charvat H; Fukui K; Matsuda T; Katanoda K; Ito Y
    Int J Cancer; 2023 Sep; 153(6):1162-1171. PubMed ID: 37278616
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study.
    Rabbani S; Mattsson F; Lagergren J; Xie S
    Acta Oncol; 2023 May; 62(5):438-443. PubMed ID: 37216488
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian cancer, and Mario Negri Gynecologic Oncology Group Groups.
    Macchia G; Pezzulla D; Campitelli M; Laliscia C; Fodor A; Bonome P; Draghini L; Ippolito E; De Sanctis V; Ferioli M; Titone F; Balcet V; Di Cataldo V; Russo D; Vicenzi L; Cossa S; Lucci S; Cilla S; Deodato F; Gambacorta MA; Scambia G; Morganti AG; Ferrandina G
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):321-332. PubMed ID: 37150261
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sex differences in treatment allocation and survival of potentially curable gastroesophageal cancer: A population-based study.
    Kalff MC; Dijksterhuis WPM; Wagner AD; Oertelt-Prigione S; Verhoeven RHA; Lemmens VEPP; van Laarhoven HWM; Gisbertz SS; van Berge Henegouwen MI
    Eur J Cancer; 2023 Jul; 187():114-123. PubMed ID: 37146505
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy.
    Gervaso L; Bottiglieri L; Meneses-Medina MI; Pellicori S; Biffi R; Fumagalli Romario U; De Pascale S; Sala I; Bagnardi V; Barberis M; Cella CA; Fazio N
    Clin Transl Oncol; 2023 Nov; 25(11):3287-3295. PubMed ID: 37084152
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Two decades of gastric and gastroesophageal junction cancer surgery.
    Plum PS; Pamuk A; Barutcu AG; Mallmann C; Niesen E; Berlth F; Zander T; Chon SH; Moenig SP; Quaas A; Bruns CJ; Hoelscher AH; Alakus H
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7679-7688. PubMed ID: 37000260
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.